Pathologic seminal vesicle invasion after radical prostatectomy for patients with prostate carcinoma: Effect of early adjuvant radiation therapy on biochemical control

Cancer

Volumn 82, Issue 10, 1998, Pages 1909-1914

  Valicenti, Richard K ^a,b   Gomella, Leonard G ^a   Ismail, Mohammed ^a   Mullholland, S Grant ^a   Petersen, Robert O ^a   Corn, Benjamin W ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Prostate carcinoma; Prostate specific antigen; Radiation therapy; Seminal vesicle invasion

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; SEMINAL VESICLE DISEASE; TREATMENT OUTCOME;

ADENOCARCINOMA; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; GENITAL NEOPLASMS, MALE; HUMANS; MALE; NEOPLASM INVASIVENESS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; SALVAGE THERAPY; SEMINAL VESICLES; TIME FACTORS;

EID: 0032525171     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980515)82:10<1909::AID-CNCR14>3.0.CO;2-X     Document Type: Article

References (25)

1. McNeal JE, Kindrachuk RA, Freiha FS, Bostwick DG, Redwine EA, Stamey TA. Patterns of progression in prostate cancer. Lancet 1986;11:60-3.
2. Mukamel E, DeKernion JB, Hannah J, Smith RB, Skinner DG, Goodwin WE. The incidence and significance of seminal vesicle invasion in patients with adenocarcinoma of the prostate. Cancer 1987;59:1535-8.
3. Epstein JI, Carmichael M, Walsh PC. Adenocarcinoma of the prostate invading the seminal vesicle: definition and relation of tumor volume, grade and margins of resection to prognosis. J Urol 1993;149:1040-5.
4. Ohori M, Scardino PT, Lapin SL, Seale-Hawkins C, Link J, Wheeler TM. The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Am J Surg Pathol 1993;17:1252-61.
5. Villers AA, McNeal JE, Redwine EA. Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma. J Urol 1990;143:1183-7.
6. Schild SE, Wong WW, Grado GL, Buskirk SJ, Robinow JS, Frick LM, et al. Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy. Mayo Clin Proc 1994;69:613-9.
7. Freeman JA, Lieskovsky G, Cook DW, Petrovich Z, Chen SC, Groshen S, et al. Radical retropubic prostatectomy and post-operative adjuvant radiation for pathological Stage C (PCNO) prostate cancer from 1976 to 1989: intermediate findings. J Urol 1993;149:1029-34.
8. Zietman AL, Coen JJ, Shipley WU, Althausen AF. Adjuvant irradiation after radical prostatectomy for adenocarcinoma of prostate: analysis of freedom from PSA failure. Urology 1993;42:292-9.
9. Zietman AL, Edelstein RA, Coen JJ, Babayan RK, Krane RJ. Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathologic findings on biochemical disease-free outcome. J Urol 1994;43:828-33.
10. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907.
11. Lange PH, Ercole CI, Lightner DJ, Fraley EE, Vessella R. The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 1989;141:873.
12. Partin AW, Oesterling JE. The clinical usefulness of prostate specific antigen: update 1994. J Urol 1994;152:1358.
13. Ploch NR, Brawer MK. How to use prostate-specific antigen. Urology 1994;43(Suppl. 2):27.
14. Morgan WR, Zincke H, Rainwater LM, Myers RP, Klee GG. Prostate specific antigen values after radical retropuhic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation). J Urol 1991;145:319-23.
15. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, editors. Manual for staging of cancer. 4th edition. American Joint Commission on Cancer. Philadelphia: J. B. Lippincott, 1992.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-62.
17. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc A 1972;135:185-92.
18. Cox DR. Regression models and life tables. J R Stat Soc 1982;34:187.
19. Wu JJ, King SC, Montana GS, McKinstry CA, Anscher MS. The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen. Int J Radiat Oncol Biol Phys 1995;32:317-23.
20. Schild SE, Wong WW, Grado GL, Halyard MY, Novicki DE, Swanson SK, et al. The results of radical retropubic prostatectomy and adjuvant therapy for pathologic stage C prostate cancer. Int J Radiat Oncol Biol Phys 1996;34:535-41.
21. Anscher MS, Prosnitz LR. Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule. J Urol 1987;138:1407-12.
22. Walsh PC, Jewett HJ. Radical surgery for prostatic cancer. Cancer 1980;45:1906-11.
23. Jewett JC, Eggleston JC, Yawn DH. Radical prostatectomy in the management of carcinoma of the prostate: probable causes of some therapeutic failures. J Urol 1972;107:1034-40.
24. Eisbruch A, Perez CA, Roessler EH, Lockett MA. Adjuvant irradiation after prostatectomy for carcinoma of the prostate with positive surgical margins. Cancer 1994;73:384-7.
25. Valicenti RK, Gomella LG, Ismail M, Mulholland SG, Petersen RO, Corn BW. Effect of higher radiation dose on biochemical control after radical prostatectomy for pT3N0 prostate cancer. Int J Radiat Oncol Biol Phys 1997;39(Suppl 2):222.